Opinion

Video

Zanubrutinib-Based Treatment Clinical Trial Updates

Expert perspectives on the SEQUOIA study, which is investigating zanubrutinib in patients with chronic lymphocytic leukemia.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Picture of Dr. Jacob Sands
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.